Another tough day for COVID VACCINE STOCKS with one exception. Altimmune climbed 16.5% on some non-covid vaccine clinical results.
Two of three stocks lost ground and the overall average was a loss of 0.8%.
Leading on the downside, was Tonix which fell 7.5%, then BioNTech, Generex and Novavax which fell 6%.
No comments:
Post a Comment